Nisa Investment Advisors’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $611 | Buy |
1,471
+771
| +110% | +$320 | ﹤0.01% | 2837 |
|
2025
Q1 | $436 | Sell |
700
-2
| -0.3% | -$1 | ﹤0.01% | 2824 |
|
2024
Q4 | $1.17K | Buy |
702
+42
| +6% | +$70 | ﹤0.01% | 2641 |
|
2024
Q3 | $1.2K | Buy |
660
+54
| +9% | +$98 | ﹤0.01% | 2531 |
|
2024
Q2 | $3.65K | Buy |
606
+204
| +51% | +$1.23K | ﹤0.01% | 2303 |
|
2024
Q1 | $4.48K | Buy |
402
+10
| +3% | +$111 | ﹤0.01% | 2132 |
|
2023
Q4 | $5.84K | Hold |
392
| – | – | ﹤0.01% | 2112 |
|
2023
Q3 | $1.88K | Buy |
392
+10
| +3% | +$48 | ﹤0.01% | 2346 |
|
2023
Q2 | $2.87K | Hold |
382
| – | – | ﹤0.01% | 2350 |
|
2023
Q1 | $2K | Buy |
382
+32
| +9% | +$168 | ﹤0.01% | 2309 |
|
2022
Q4 | $4K | Hold |
350
| – | – | ﹤0.01% | 2305 |
|
2022
Q3 | $4K | Hold |
350
| – | – | ﹤0.01% | 2312 |
|
2022
Q2 | $3K | Sell |
350
-600
| -63% | -$5.14K | ﹤0.01% | 2307 |
|
2022
Q1 | $16K | Sell |
950
-2,050
| -68% | -$34.5K | ﹤0.01% | 2105 |
|
2021
Q4 | $48K | Buy |
+3,000
| New | +$48K | ﹤0.01% | 1743 |
|